[Sporeless anaerobic bacteria with special reference to resistance testing and resistance behavior].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001421:Bacteria, Anaerobic / Q000187:drug effects*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D001431:Bacteriological Techniques; D002440:Cefoxitin / Q000627:therapeutic use; D002981:Clindamycin / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D008795:Metronidazole; D002981:Clindamycin; D002440:Cefoxitin
Die sporenlosen Anaerobier unter besonderer Berücksichtigung der Resistenztestung und des Resistenzverhaltens.